Cargando…

Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, pathologically hallmarked by the loss of dopamine neurons in the substantia nigra (SN) and alpha-synuclein aggregation. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a common target to treat the motor symptoms i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazumder, Srestha, Bahar, Anita Y., Shepherd, Claire E., Prasad, Asheeta A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516394/ https://www.ncbi.nlm.nih.gov/pubmed/36188463 http://dx.doi.org/10.3389/fnins.2022.948523

Ejemplares similares

Ultra-High Field MRI Post Mortem Structural Connectivity of the Human Subthalamic Nucleus, Substantia Nigra, and Globus Pallidus
por: Plantinga, Birgit R., et al.
Publicado: (2016)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients
por: Hidding, U., et al.
Publicado: (2017)

The Subcortical Cocktail Problem; Mixed Signals from the Subthalamic Nucleus and Substantia Nigra
por: de Hollander, Gilles, et al.
Publicado: (2015)

Not Part of the Temporal Lobe, but Still of Importance? Substantia Nigra and Subthalamic Nucleus in Epilepsy
por: Bröer, Sonja
Publicado: (2020)

Automated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7 T data at young and old age
por: Visser, Eelke, et al.
Publicado: (2016)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Combined Stimulation of the Substantia Nigra and the Subthalamic Nucleus for the Treatment of Refractory Gait Disturbances in Parkinson’s Disease: A Preliminary Study
por: Villadóniga, Marta, et al.
Publicado: (2022)

Bidirectional Optogenetic Modulation of the Subthalamic Nucleus in a Rodent Model of Parkinson’s Disease
por: Xie, Caroline, et al.
Publicado: (2022)

Structural integrity of the substantia nigra and subthalamic nucleus predicts flexibility of instrumental learning in older-age individuals
por: Chowdhury, Rumana, et al.
Publicado: (2013)

Analysis of morphological and neurochemical changes in subthalamic nucleus neurons in response to a unilateral 6-OHDA lesion of the substantia nigra in adult rats
por: Sedaghat, Katayoun, et al.
Publicado: (2021)

Proteome analysis of human substantia nigra in Parkinson's disease
por: Werner, Cornelius J, et al.
Publicado: (2008)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
por: Faynveitz, Anna, et al.
Publicado: (2019)

Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain
por: Bellinger, Frederick P, et al.
Publicado: (2011)

High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson’s Disease
por: Kelly, Neil A., et al.
Publicado: (2017)

Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
por: Loeffler, David A, et al.
Publicado: (2006)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
por: Trist, Benjamin G., et al.
Publicado: (2019)

Complementary Transcriptomic and Proteomic Analysis in the Substantia Nigra of Parkinson's Disease
por: Dong, Bao-hua, et al.
Publicado: (2021)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
por: Feraco, Paola, et al.
Publicado: (2021)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
por: Liu, Lei, et al.
Publicado: (2023)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
por: Hussain, Sayyed Shahid, et al.
Publicado: (2023)

Dopaminergic Control of the Globus Pallidus through Activation of D2 Receptors and Its Impact on the Electrical Activity of Subthalamic Nucleus and Substantia Nigra Reticulata Neurons
por: Mamad, Omar, et al.
Publicado: (2015)

Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients
por: Sadowski, Krzysztof, et al.
Publicado: (2011)

Altered functional connectivity of the red nucleus and substantia nigra in migraine without aura
por: Huang, Xiaobin, et al.
Publicado: (2019)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson's Disease
por: Romeo, Stefania, et al.
Publicado: (2014)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
por: Reeve, Amy K., et al.
Publicado: (2018)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Substantia Nigra Integrity Correlates with Sequential Working Memory in Parkinson's Disease
por: Liu, Wenyue, et al.
Publicado: (2021)

Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
por: De la Casa-Fages, Beatriz, et al.
Publicado: (2011)

Subthalamic Nucleus Deep Brain Stimulation Impacts Language in Early Parkinson's Disease
por: Phillips, Lara, et al.
Publicado: (2012)

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: Why so successful?
por: Kocabicak, Ersoy, et al.
Publicado: (2012)

Deep Brain Stimulation of the Subthalamic and Pedunculopontine Nucleus in a Patient with Parkinson's Disease
por: Liu, Huan-Guang, et al.
Publicado: (2015)

The effect on deep brain stimulation of subthalamic nucleus and dopaminergic treatment in Parkinson disease
por: Lo Buono, Viviana, et al.
Publicado: (2020)

How is cognition in subthalamic nucleus deep brain stimulation Parkinson’s disease patients?
por: Barboza e Barbosa, Eduarda Naidel, et al.
Publicado: (2019)

Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson’s disease
por: Zhang, Feng, et al.
Publicado: (2022)

Predict initial subthalamic nucleus stimulation outcome in Parkinson's disease with brain morphology
por: Chen, Yingchuan, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
por: Liu, Weibing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fs77qi1f0rj14j527624vo5bg3